Bartlett & Co’s Rentokil RTO Stock Holding History

Bartlett & Co’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-569	Closed	-$21K	–	1244
2023 Q3	$21K	Hold	569	–	–	﹤0.01%	816
2023 Q2	$22K	Hold	569	–	–	﹤0.01%	806
2023 Q1	$21K	Hold	569	–	–	﹤0.01%	703
2022 Q4	$18K	Buy	+569	New	+$17.7K	﹤0.01%	734

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

Bartlett & Co's RTO Position: Q4 2023 in Review

Bartlett & Co sold out of Rentokil (RTO) in Q4 2023, closing a stake of 569 shares — an estimated $21K sold.

Bartlett & Co first reported a position in RTO in Q4 2022 and held it in 4 quarters. The position peaked at $22K in Q2 2023. 188 funds tracked by Wall St. Rank hold RTO as of Q4 2023.

Bartlett & Co reported no remaining Rentokil position as of Q4 2023 after selling out during the quarter.
Bartlett & Co sold 569 Rentokil shares in Q4 2023, an estimated $21K.
Bartlett & Co first reported a position in Rentokil in Q4 2022 and held it in 4 quarters.
Bartlett & Co's Rentokil position peaked at $22K in Q2 2023.
188 funds tracked by Wall St. Rank held Rentokil as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.